A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer
Year: 2013
Type: article
Source: Gynecologic Oncology
Institutions: UPMC Health System, Magee-Womens Hospital, Duke Medical Center, Duke Cancer Institute, Hahnemann University Hospital, University of Alabama at Birmingham, Brown University, The University of Texas MD Anderson Cancer Center, Sarasota Memorial Health Care System, Sarasota Memorial Hospital, Holy Cross Hospital, Precision Therapeutics (United States), Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2147407338
